Drug Shortage Report for CEFTAZIDIME FOR INJECTION BP

Last updated on 2025-02-03 History
Report ID 249450
Drug Identification Number 02437856
Brand name CEFTAZIDIME FOR INJECTION BP
Common or Proper name CEFTAZIDIME FOR INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFTAZIDIME
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-03-31
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2025-02-03
Company comments Inventory remains available at SteriMax and McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2025-02-03 French Compare
v1 2025-02-03 English Compare

Showing 1 to 2 of 2